Design Therapeutics Inc. (DSGN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Design Therapeutics Inc.

    NASDAQ: DSGN · Real-Time Price · USD
    6.08
    0.07 (1.08%)
    At close: Oct 03, 2025, 3:19 PM

    Design Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -49.59M -66.86M -63.31M -35.53M
    Depreciation & Amortization
    		 -5.6M 537K 406K 129K
    Stock-Based Compensation
    		 13.07M 13.09M 10.93M 4.69M
    Other Working Capital
    		 226K 1.97M -3.39M -1.02M
    Other Non-Cash Items
    		 6K -6.05M -1.33M 19K
    Deferred Income Tax
    		 n/a n/a n/a -77K
    Change in Working Capital
    		 -993K 728K 1.99M 1.4M
    Operating Cash Flow
    		 -43.1M -58.56M -51.32M -29.38M
    Capital Expenditures
    		 -340K -256K -918K -1.54M
    Cash Acquisitions
    		 n/a n/a 39K 52.11K
    Purchase of Investments
    		 -230.18M -224.7M -313M -86.26M
    Sales Maturities Of Investments
    		 274.47M 277.5M 92.89M 34.16M
    Other Investing Acitivies
    		 n/a n/a n/a -52.11K
    Investing Cash Flow
    		 43.95M 52.54M -220.99M -53.64M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a -427K 228K
    Financial Cash Flow
    		 513K 724K 235K 379.21M
    Net Cash Flow
    		 1.36M -5.3M -272.07M 296.19M
    Free Cash Flow
    		 -43.45M -58.82M -52.23M -30.91M

    Add to Watchlist